Sep 08, 2015 | admin
Transvaginal mesh is used to support the body’s organs following surgery to correct a condition known as pelvic organ prolapse in female patients. But the device can deteriorate or become embedded in body tissue, causing pain, irritation, or perforation of the organs that requires further surgery to correct.
Thousands of transvaginal mesh failure cases have been reported over the years, and many have resulted in lawsuits against the manufacturers of the devices. Now, many of these cases may soon be resolved as the result of a proposed settlement agreement.
Reports from Bloomberg Business indicate transvaginal mesh maker, C.R. Bard, Inc., has offered an agreement that would bring an end to roughly 3,000 transvaginal mesh failure lawsuits. If the terms of the settlement are approved, roughly 20 percent of all transvaginal mesh failure lawsuits will be resolved.
Documents show that Bard would pay $200 million to those harmed by their product. Individual victims would receive roughly $67,000 for their injuries and damages.
The decision to settle comes in the wake of Bard recently being ordered to pay $2 million to a woman injured by the company’s transvaginal mesh.
Victims of faulty medical devices deserve compensation for their damages, and the defective product lawyers at CHASENBOSCOLO Injury Lawyers hope a settlement is agreed upon that helps bring closure to patients harmed by transvaginal mesh.